Cargando…

Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis

Atherosclerosis is a chronic inflammatory disorder characterised by the accumulation of monocytes/macrophages, smooth muscle cells, and lymphocytes within the arterial wall in response to the release of proinflammatory molecules. Such accumulation results in the formation of the atherosclerotic plaq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milioti, Natalia, Bermudez-Fajardo, Alexandra, Penichet, Manuel L., Oviedo-Orta, Ernesto
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423423/ https://www.ncbi.nlm.nih.gov/pubmed/18551190 http://dx.doi.org/10.1155/2008/723539

Ejemplares similares

Incretin hormones as immunomodulators of atherosclerosis
por: Alonso, Nuria, et al.
Publicado: (2012)

Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future
por: Lecis, Dalgisio, et al.
Publicado: (2023)

Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
por: Silvis, Max J. M., et al.
Publicado: (2020)

The Role of Macrophages in the Pathogenesis of Atherosclerosis
por: Blagov, Alexander V., et al.
Publicado: (2023)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
por: Pfeil, Jennifer, et al.
Publicado: (2020)

The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis
por: Dehnavi, Sajad, et al.
Publicado: (2019)

Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
por: Kimura, Yoshitaka, et al.
Publicado: (2021)

The Potential Role of Connexins in the Pathogenesis of Atherosclerosis
por: Kiełbowski, Kajetan, et al.
Publicado: (2023)

Recent advances in pathogenesis, assessment, and treatment of atherosclerosis
por: Spence, J. David
Publicado: (2016)

New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis
por: Wu, Meng-Yu, et al.
Publicado: (2017)

Telomeres and Estrogens: The Unholy Nexus in Pathogenesis of Atherosclerosis
por: Sameer, Aga Syed, et al.
Publicado: (2014)

Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
por: Ciccarelli, Giovanni, et al.
Publicado: (2023)

Cholinergic immunomodulation in inflammatory bowel diseases
por: Serafini, Michele A., et al.
Publicado: (2021)

Immunomodulators for Asthma
por: Dimov, Vesselin V, et al.
Publicado: (2010)

Schistosome immunomodulators
por: Acharya, Sreemoyee, et al.
Publicado: (2021)

A Novel Transport Mechanism for MOMP in Chlamydophila pneumoniae and Its Putative Role in Immune-Therapy
por: Atanu, Francis O., et al.
Publicado: (2013)

Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma
por: Dumolard, Lucile, et al.
Publicado: (2020)

High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis
por: Bale, Bradley Field, et al.
Publicado: (2017)

Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
por: Shemiakova, Taisiia, et al.
Publicado: (2020)

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Atherosclerosis, Cardiovascular Disorders and COVID-19: Comorbid Pathogenesis
por: Makarova, Yulia A., et al.
Publicado: (2023)

T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease
por: Hinkley, Hannah, et al.
Publicado: (2023)

Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications
por: Durairajan, Siva Sundara Kumar, et al.
Publicado: (2023)

MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?
por: Li, Heng, et al.
Publicado: (2018)

An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis
por: Dahal, Udip, et al.
Publicado: (2017)

ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
por: Jiang, Chunteng, et al.
Publicado: (2021)

X-box Binding Protein 1: An Adaptor in the Pathogenesis of Atherosclerosis
por: Wang, Tao, et al.
Publicado: (2023)

Immunomodulation in Pancreatic Cancer
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2020)

Gastrointestinal injury induced by immunomodulators: A review article
por: Zhang, Pingxin, et al.
Publicado: (2023)

The Role of DNA Damage Response in Dysbiosis-Induced Colorectal Cancer
por: Rivas-Domínguez, Antonio, et al.
Publicado: (2021)

The significance of Agaricus blazei as an immunomodulator of the level of IL-17 in Balb/C mice with atherosclerosis
por: TONTOWIPUTRO, DICKY KURNIAWAN, et al.
Publicado: (2020)

The role of calmodulin and calmodulin-dependent protein kinases in the pathogenesis of atherosclerosis
por: Chen, Mei-Fang
Publicado: (2021)

Immunomodulators in chronic rhinosinusitis
por: Lavigne, Philippe, et al.
Publicado: (2018)

Immunomodulation in the critically ill
por: Webster, N.R., et al.
Publicado: (2009)

Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens
por: Riitho, Victor, et al.
Publicado: (2017)

Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
por: Guilford, Timothy, et al.
Publicado: (2010)

Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
por: Rangarajan, Subhapradha, et al.
Publicado: (2022)

Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability
por: Nieddu, Gabriele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_76vd8kn3263got2cvj0nnkd51t